U.S. stocks are headed for a rough start, due to a global sell-off and sinking crude prices. Among the equities in focus are financial concern Goldman Sachs Group Inc (NYSE:GS), biotech issue Zafgen Inc (NASDAQ:ZFGN), and tech blue chip Apple Inc. (NASDAQ:AAPL).